External resources and information about the regulation of medicines and medical devices if there is a no-deal Brexit
The MHRA is publishing a series of guidance documents for industry and other stakeholders covering our proposed arrangements for the regulation of medicines, medical devices and clinical trials, if there is a no-deal Brexit.
Overall approach to regulation in a no-deal Brexit
Marketing authorisations, variations and licensing guidance
Importing and exporting
Medicines for children
Medical devices
Legislation concerning a no deal scenario
Regulatory submissions and vigilance activities
Vaccines and blood products
Technical notices